INS and autosomal agammaglobulinemia: Furthermore, at this time, serum γ-GT, ALT, and AST activities were significantly reduced, and the changed serum CPR concentrations during the 12-week intervention decreased in the AGM group (p = 0.069), which suggested AGM reduced insulin resistance and liver damage and thus, improved hepatic insulin sensitivity.